HLA-B62 as a possible ligand for the human homologue of mouse macrophage MHC receptor 2 (MMR2) on monocytes

Gene

Volumn 454, Issue 1-2, 2010, Pages 31-38

  Shimizu, Tetsunosuke ^a   Tashiro Yamaji, Junko ^a   Hayashi, Michihiro ^a   Inoue, Yoshihiro ^a   Ibata, Minenori ^a   Kubota, Takahiro ^a   Tanigawa, Nobuhiko ^a   Yoshida, Ryotaro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

HLA; Human; Monocyte; PBMC; Receptor

Indexed keywords

COMPLEMENTARY DNA; HLA B ANTIGEN; HLA B62 ANTIGEN; MACROPHAGE MHC RECEPTOR 2; MESSENGER RNA; PROTEIN; PROTEIN KINASE C; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; LIGAND; MMR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CROSS REACTION; DNA SEQUENCE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANIMAL; CELL LINE; GENE LIBRARY; GENETICS; METABOLISM; SEQUENCE HOMOLOGY;

MUS;

ANIMALS; CELL LINE; GENE LIBRARY; HLA-B ANTIGENS; HUMANS; LIGANDS; MACROPHAGES; MICE; RECEPTORS, IMMUNOLOGIC; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 77952513108     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2010.01.007     Document Type: Article

References (40)

1. Akashi S., et al. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: higher affinity than with MD-2 or CD14. J. Exp. Med. 2003, 198:1035-1042.
2. Corr M., et al. T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 1994, 265:946-949.
3. -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 1996, 156:4114-4119.
4. Dausset J. Iso-leuco-antibodies. Acta Haematol. 1958, 20:156-166.
5. + cytotoxic T lymphocyte clones. J. Exp. Med. 1982, 156:1280-1285.
6. Goodenow R.S., et al. Identification of the class I genes of the mouse major histocompatibility complex by DNA-mediated gene transfer. Nature 1982, 300:231-237.
7. Gorer P.A. The detection of antigenic differences in mouse erythrocytes by the employment of immune sera. Br. J. Exp. Pathol. 1936, 17:42-50.
8. Hall B.M. Cells mediating allograft rejection. Transplantation 1991, 51:1141-1151.
9. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
10. + cells are essential for allorejection. J. Exp. Med. 1996, 184:2013-2018.
11. Kronenberg M., Siu G., Hood L.E., Shastri N. The molecular genetics of the T-cell antigen recognition. Ann. Rev. Immunol. 1986, 4:529-591.
12. Lamm L.U., Friedrich U., Petersen C.B. Assignment of the major histocompatibility complex to chromosome 6 in a family with a pericentric inversion. Hum. Hered. 1974, 24:273-284.
13. Lee K., et al. Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL. Microbiol. Immunol. 2004, 48:15-25.
14. Lienert-Weidenbach K., et al. Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling. Biol. Blood Marrow Transplant. 1997, 3:255-260.
15. Little A.-M., Parham P. Polymorphism and evolution of classIandII genes and molecules. Rev. Immunogenet. 1999, 1:105-123.
16. Mintz B., Silvers W.K. "Intrinsic" immunological tolerance in allophenic mice. Science 1967, 158:1484-1486.
17. Mintz B., Silvers W.K. Histocompatibility antigens on melanoblasts and hair follicle cells: cell-localized homograft rejection in allophenic skin grafts. Transplantation 1970, 9:497-505.
18. Mori M., Beatty P.G., Graves M., Boucher K.M., Milford E.L. HLA gene and haplotype frequencies in the North American population. The National Marrow Donor Program Donor Registry. Transplantation 1997, 64:1017-1027.
19. + T cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:3171-3175.
20. Nomi H., et al. Acute rejection of allografted, CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice. J. Immunol. 2007, 179:2180-2186.
21. b) mice. Microbiol. Immunol. 2007, 51:297-306.
22. Okada M., et al. Regulation of hair regrowth in alopecic site of IFN-γ-/- mice by macrophages infiltrating into allograft in IFN-γ+/+ mice. J. Interferon Cytokine Res. 2005, 25:564-574.
23. Staats J. Standardized nomenclature for inbred strains of mice: sixth listing. Cancer Res. 1976, 36:4333-4377.
24. d, in mice. Microbiol. Immunol. 2006, 50:105-116.
25. d, in mice. Gene 2006, 384:1-8.
26. Ushio Y., Yamamoto N., Sanchez-Bueno A., Yoshida R. Failure to reject an allografted tumor after elimination of macrophages in mice. Microbiol. Immunol. 1996, 40:489-498.
27. Ushio-Umeda Y., Yoshida R. Mechanisms of allografted tumor rejection: the roles of T cells in allograft rejection mediated by a type of bone marrow-derived macrophage. Microbiol. Immunol. 1997, 41:981-990.
28. van Someren H., Westerweld A., Hagmeijer A., Mees J.R., Mera Khan P., Zaalberg O.B. Human antigens and enzyme markers in man-Chinese hamster somatic cell hybrids: evidence for synteny between the HLA, PGM3, ME1 and IPO-B loci. Proc. Natl Acad. Sci. USA 1974, 71:962-965.
29. Yamaguchi S., et al. IFN-γ: a cytokine essential for rejection of CTL-resistant, virus-infected cells. J. Interferon Cytokine Res. 2005, 25:328-337.
30. Yamamoto N., Einaga-Naito K., Kuriyama M., Kawada Y., Yoshida R. Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation 1998, 65:818-825.
31. Yokoyama W.M. Natural killer cell receptors specific for major histo-compatibility complex class I molecules. Proc. Natl Acad. Sci. USA 1995, 92:3081-3085.
32. Yoneda Y., Tashiro-Yamaji J., Kubota T., Yoshida R. Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells. Microbiol. Immunol. 2008, 52:347-354.
33. Yoneda Y., Yoshida R. The role of T cells in allografted tumor rejection: IFN-γ released from T cells is essential for induction of effector macrophages in the rejection site. J. Immunol. 1998, 160:6012-6017.
34. Yoshida R., Matsuura A., Einaga K., Ushio Y., Yamamoto N., Yoneda Y. Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection site: infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol. Immunol. 1997, 41:149-159.
35. Yoshida R., et al. Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts. Microbiol. Immunol. 2000, 44:57-67.
36. Yoshida R., Park S.W., Yasui H., Takikawa O. Tryptophan degradation in transplanted tumor cells undergoing rejection. J. Immunol. 1988, 141:2819-2823.
37. 2+-dependent, Fas- and perforin-independent apoptotic death of allograft tumor cells by a type of activated macrophage. J. Immunol. 1997, 159:15-21.
38. Yoshida R., Takikawa O., Oku T., Habara-Ohkubo A. Mononuclear phagocytes: a major population of effector cells responsible for rejection of allograft tumor cells in mice. Proc. Natl. Acad. USA 1991, 88:1526-1530.
39. Yoshida R., Yoneda Y., Kuriyama M., Kubota T. IFN-γ- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. J. Immunol. 1999, 163:148-154.
40. 2-microglobulin-deficient mice. J. Exp. Med. 1992, 175:885-893.